The Report Ocular Drug Delivery Technology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz". This report on the Global Ocular Drug Delivery Technology market analyzes the current and future scenario of the global market. Rise in private and public funding for R&D of novel drug delivery technologies, increase in prevalence of macular degeneration & diabetic retinopathy, and favorable regulatory scenario for introduction of innovative technologies are boosting the growth of the Global Ocular Drug Delivery Technology market. Rising demand for targeted drug delivery to the affected ocular tissue, and elimination of drug due to nasolacrimal drainage system when administered via topical route are some of the factors expected to drive the growth of Global Ocular Drug Delivery Technology market during the forecast ...
Plants are natures remedies and have been used by human beings on earth since ancient times for food and medicine. Today there are global movements towards finding of herbal medicaments in plants to bring them in market via a suitable drug delivery system for mankind. The basic thought behind it is treatment of each disease is hidden in nature. However, delivery of herbal drugs also requires modification with the purpose to achieve sustain release, to increase patient compliance etc. previously herbal drugs could not attract scientists towards the modifications of novel drug delivery systems due to processing, standardizing, extracting and identification difficulties. But now days with the advancement in the technology, novel drug delivery systems (NDDS) open the door towards the development of herbal novel drug delivery system. With use of advance techniques protection from toxicity, enhancement in stability, improved bioavailability of herbal formulations, protection from physical and ...
Further in the Controlled-Release Drug Delivery Technology Market research report, following points are included along with in-depth study of each point:. • Production Analysis- Production of the Controlled-Release Drug Delivery Technology is analysed with respect to different regions, types and applications. Here, price analysis of various Controlled-Release Drug Delivery Technology Market key players is also covered.. • Sales and Revenue Analysis- Both, sales and revenue are studied for the different regions of the global Controlled-Release Drug Delivery Technology Market. another major aspect, price, which plays important part in the revenue generation is also assessed in this section for the various regions.. • Supply and Consumption- In continuation with sales, this section studies supply and consumption for the Controlled-Release Drug Delivery Technology Market. This part also sheds light on the gap between supple and consumption. Import and export figures are also given in this ...
Market experts suggest that, There is a continuous growth in the market of drug delivery systems and will continue to grow at an impressive rate in future also. The novel drug delivery technologies enable to formulate the novel drug delivery devices by incorporating the drug molecules into new delivery systems, thus providing numerous therapeutic and commercial advantages. It was observed that NDDS market was segmented on the basis of route of administration, type of carrier and geographical region. In route of administration segment, injectable drug delivery system was observed as the largest market in 2015 followed by oral drug delivery system. Injectable drug delivery system comprises of several benefits over other dosage forms in cases such as unconsciousness, nausea, in emergency clinical episodes. The injectable administration route is the most common and efficient for delivery of active drug substances with poor bio-availability and the drugs with a narrow therapeutic index. On the basis ...
Michael J. Rathbone This two volume Second Edition of Modified-Release Drug Delivery Technology describes the anatomical, physiological, pharmaceutical, and technological aspects of oral, colonic and rectal, ocular, oral mucosal, dermal and transdermal, nasal, vaginal, and pulmonary delivery routes.. Modified-Release Drug Delivery Technology provides insight and critical assessment of the many available and emerging modified release drug delivery systems for their current and future value.. Modified-Release Drug Delivery Technology is available as a 2-volume set or each volume may be purchased individually.. Contents and information on Volume One ...
A team of UC Davis scientists has shown in experimental mouse models that a new drug delivery system allows for administration of three times the maximum tolerated dose of a standard drug therapy for advanced bladder cancer, ...
Novel drug delivery systems are now a days is creating a new interest in development of drug deliveries. Vesicular drug delivery system is also a part of these novel drug delivery systems. TDDS is the permeability of the skin, it is permeable to small molecules, lipophilic drug and highly impermeable to the macromolecules and hydrophilic drugs. Recent approaches have resulted in design of two vesicular carriers, ethosomes and ultra flexible lipid based elastic vesicles, transferosomes. Transferosomes have recently been introduced, which are capable of transdermal delivery of low as well as high molecular weight drugs. This offers several potential advantages over conventional routes like avoidance of first pass metabolism, predictable and extended duration of activity, minimizing undesirable side effects, utility of short half life drugs, improving physiological and pharmacological response and have been applied to increases the efficiency of the material transfer across the intact skin, by the use of
Summary. Latest report, ""Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during the Forecast Period"" discusses the drug delivery technologies and trends in the market and the evolving business strategies being adopted and leveraged by companies globally.. The ultimate goal of drug delivery research is to develop formulations and devices that can be used in clinical applications to treat various diseases. Delivering a drug with the desired release kinetics requires an understanding of the underlying physicochemical properties of the drug, which determine the type of delivery material and drug release mechanism.. Numerous parameters need to be considered, and their inter-dependence has to be taken into account to develop successful drug delivery systems for the intended applications. It is important to understand the complexity associated with the development of a drug delivery system that can ultimately be ...
TY - JOUR. T1 - Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. AU - Cheng, Yu. AU - Samia, Anna C.. AU - Meyers, Joseph D.. AU - Panagopoulos, Irene. AU - Fei, Baowei. AU - Burda, Clemens. PY - 2008/8/13. Y1 - 2008/8/13. N2 - A highly efficient drug vector for photodynamic therapy (PDT) drug delivery was developed by synthesizing PEGylated gold nanoparticle conjugates, which act as a water-soluble and biocompatible "cage" that allows delivery of a hydrophobic drug to its site of PDT action. The dynamics of drug release in vitro in a two-phase solution system and in vivo in cancer-bearing mice indicates that the process of drug delivery is highly efficient, and passive targeting prefers the tumor site. With the Au NP-Pc 4 conjugates, the drug delivery time required for PDT has been greatly reduced to less than 2 h, compared to 2 days for the free drug.. AB - A highly efficient drug vector for photodynamic therapy (PDT) drug delivery was ...
The global novel drug delivery systems (NDDS) in cancer therapy market size was valued at USD 4.31 billion in 2016 and is projected to grow at a CAGR of 22.9% during the forecast period. Worldwide increasing incidence of cancer, availability of research funding, increase in awareness about alternative methods for treatment, and favorable reimbursement scenarios in developed nations are some of the key drivers of this market.
World Congress on Pharmaceutics & Novel Drug Delivery Systems on Jun 15, 2020 in Zurich, Switzerland at Zurich, Switzerland. Ology Mavens is hosting...
Novel Drug Delivery Systems Market Was Valued At USD 165.4 Bn In 2015, And Is Expected To Reach USD 202.5 Bn By 2022, Expanding At A CAGR Of 2.7% From 2016 To 2022
http://www.marketsandmarkets.com/Market-Reports/drug-delivery-technologies-market-1085.html. Drug delivery technologies alter the release of drug so as to facilitate optimum efficacy and safety.Such technologies simplify the dosing regimen and reduce side-effects, thus boosting patient compliance. The global drug delivery market is divided into nine segments, namely, oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable,andtransmucosal. Drug delivery technologies have grown phenomenally from plain drug reformulation and release technologies to innovative platforms that hold a huge potential for the effective delivery of biologicals and novel drugs.. The major drivers of this market are patent expiries of certain blockbuster drugs, growing demand for self administration and home healthcare devices, rising incidence of chronic diseases such as cardiovascular diseases, diabetes and cancer, growing focus on pediatric and geriatric patients, and advancing technology.However, ...
TY - JOUR. T1 - Standpoint on the priority of TNTs and CNTs as targeted drug delivery systems. AU - Ranjous, Yasmin. AU - Regdon, Géza. AU - Pintye-Hódi, K.. AU - Sovány, Tamás. PY - 2019/1/1. Y1 - 2019/1/1. N2 - Conventional drug delivery systems have limitations according to their toxicity and poor solubility, bioavailability, stability, and pharmacokinetics (PK). Here, we highlight the importance of functionalized titanate nanotubes (TNTs) as targeted drug delivery systems. We discuss the differences in the physicochemical properties of TNTs and carbon nanotubes (CNTs) and focus on the use of functionalization to improve their characteristics. TNTs are promising materials for drug delivery systems because of their superb properties compared with CNTs, such as their processability, wettability, and biocompatibility. Functionalization improves nanoparticles (NPs) via their surface modification and enables them to achieve the targeted therapy.. AB - Conventional drug delivery systems have ...
Niosomes are non-ionic surfactant based liposomes. Niosomes, the novel drug delivery system are self assembled vesicles primarily of synthetic surfactant incorporated with cholesterol as an excipient. They are the vesicles formed by hydrating the cholesterol and non-ionic surfactant. The main aim of niosome includes use of drug in efficient manner which includes reduced dose, reduced side effect, reduced dosage frequency, greater patient compliance and maximum concentration at the site of action so, that under exposure to the entire body. It includes higher therapeutic efficiency and reduced side effect. Niosomes are thought to be the better candidates drug delivery system due to the various factor like cost, stability, etc. various types of drug delivery is possible using niosomes like targetting drug action, ophthalmic, topical, parenteral, etc. Drug delivery potential of niosomes can be enhanced by using novel concept like proniosomes, discomes and aspasomes. Niosomes serves better aid in ...
The promise of drug delivery strategies is in their potential to improve current treatments and create opportunities for experimental therapy. Drugs that ...
ABSTRACT. Development of new drug delivery system has become the requirement of todays pharmaceutical industry. As the number of off-patent drugs and cost of new drug development increases, pharmaceutical companies are managing the life cycles of their products (from product launch to their withdrawal from the market) by adopting new and innovative delivery systems. This gives the pharmaceutical industry another chance to make the most of their current products. Oral route is the most preferred route for administration of drugs as the administration is easy and economic. But the problem is the loss of their functions due to the short residence in the body. About 80% of the administered drugs are excreted without being absorbed. This article comprehensively explains need of hydrogels and its modifications to prolong the residence time of drugs in the body, with brief introduction of associated other drug delivery systems.. Keywords: Superporous Hydrogels, Absorption Window, Stomach Specific Drug ...
drug delivery system for sale - 107901 - drug delivery system wholesalers & drug delivery system manufacturers from China manufacturers.
Thank you for your interest in spreading the word on Stroke.. NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address. ...
Wim Jiskoot graduated as a pharmacist in 1987 and received his PhD degree in 1991 at Utrecht University on pharmaceutical aspects of monoclonal antibodies. As a postdoctoral fellow at the University of Utah (1991-1993) he studied protein-ligand interactions using biophysical techniques. From 1994-1998 he was head of the Department of Bacterial Vaccine Development at the National Institute of Public Health and the Environment (RIVM), Bilthoven. In 1998 he became a staff member at the Department of Pharmaceutics, Utrecht University, where he focused his research on formulation and physicochemical characterization of therapeutic proteins and vaccines. In March 2006 he was appointed as full professor at the Division of Drug Delivery Technology, LACDR, and as the coordinator of the Biologics Research Platform Leiden (BRPL). His current research is concentrated on two themes: (1) formulation and unwanted immunogenicity of therapeutic proteins and (2) vaccine delivery.. ...
Wim Jiskoot graduated as a pharmacist in 1987 and received his PhD degree in 1991 at Utrecht University on pharmaceutical aspects of monoclonal antibodies. As a postdoctoral fellow at the University of Utah (1991-1993) he studied protein-ligand interactions using biophysical techniques. From 1994-1998 he was head of the Department of Bacterial Vaccine Development at the National Institute of Public Health and the Environment (RIVM), Bilthoven. In 1998 he became a staff member at the Department of Pharmaceutics, Utrecht University, where he focused his research on formulation and physicochemical characterization of therapeutic proteins and vaccines. In March 2006 he was appointed as full professor at the Division of Drug Delivery Technology, LACDR, and as the coordinator of the Biologics Research Platform Leiden (BRPL). His current research is concentrated on two themes: (1) formulation and unwanted immunogenicity of therapeutic proteins and (2) vaccine delivery.. ...
MUNICH, Germany, June 6, 2017 - Brainlab and Medicenna Therapeutics Corp (the "Company" or "Medicenna"; TSXV "MDNA") jointly announced today that recurrent Glioblastoma (rGB) patients in a Phase 2b clinical trial of MDNA55, a targeted immunotherapy agent, have been treated at three clinical centers in the United States using innovative drug delivery technology from Brainlab. The investigators used convection enhanced delivery (CED) to inject MDNA55, together with an imaging agent, directly into the tumor. When combined with real-time image guided MRI, CED allows delivery of MDNA55 at high concentrations into the tumor tissue while avoiding exposure to the rest of the body. The current Phase 2b clinical trial plans to enroll 43 adult patients with rGB at leading brain cancer centers in the United States.. Precise targeting is an integral part in the treatment of brain tumors to achieve significant coverage. iPlan® Flow planning software from Brainlab helps determine trajectories for drug ...
DecisionDatabases.com adds a report on 2016 Global Drug Delivery Technologies Market Status, 2011-2022 Market Historical and Forecasts, Professional Market Research Report. This research study is segmented on the bases of applications, technology and geography.
London (PRWEB) October 29, 2013 -- Report Details Drug delivery technology - discover technological and commercial prospects What does the future hold for
Research and Markets has announced the addition of the "Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Ma
A dispense interface for use with a drug delivery device. The dispense interface comprises a main outer body and an inner body. The inner body may be configured for connection to a drug delivery device and defines a first reservoir and a second reservoir. A first piercing needle is in fluid communication with the first reservoir and positioned for piercing a first cartridge of a drug delivery device. A second piercing needle is provided and in fluid communication with the second reservoir and positioned for piercing a second cartridge contained with a drug delivery device. A manifold is positioned adjacent the inner body and comprises a fluid groove arrangement. A valve arrangement is positioned between the inner body and the manifold and controls fluid communication of a first fluid contained in the first cartridge and a second fluid contained in the second cartridge by way of the fluid groove arrangement to a holding chamber. The dispense interface may further comprise a lockout preventing dispense
The present invention relates to a drug delivery system with two-step targeting, which comprises a combination: (a) a lipid carrier provided with cell targeting agent(s) to target the drug delivery system to specific cells or tissues; and (b) a drug enclosed in said lipid carrier and provided with a DNA targeting agent to target the drug to the nuclei of specific target cells. Furthermore, the invention relates to a method of cancer therapy in which the above drug delivery system is administered to a cancer patient. The goal is to treat or analyse both large tumour masses as well as small tumour cell clusters and single spread tumour cells. According to the invention, drug uptake in tumours will be markedly increased at the same time as the interaction of the drug with healthy organs and tissues can be minimized. The invention gives potential to convert palliative into curative treatment.
The global Pulmonary Drug Delivery Systems Market report provides an accurate investigation of the different patterns and parameters affecting the industrial growth of the Pulmonary Drug Delivery Systems market at a global level. An assessment of the effect of the current situation and trends in the market is additionally included to provide an overview of the markets future position. The report provides the detailed information related to the global Pulmonary Drug Delivery Systems market dynamics and demonstrates superior forecast for the development of the market and its key competitors 3M, GSK, AstraZeneca, Cipla, Chiesi, Boehringer Ingelheim, Aptar, Novartis, Philips Respironics, Omron Healthcare, PARI, Skyepharma, CareFusion, Shanghai Huarui, Taian Character, Chia Tai Tianqing based on consistent information.. Apply here for the sample copy of the report @: www.reportsbuzz.com/request-for-sample.html?repid=83030. Furthermore, The report presents a detailed segmentation Nebulizers, Dry ...
An extended release gastro-retentive drug delivery system of Valsartan. The drug delivery system contains a release portion containing the Valsartan, a gastro-retentive portion for retaining the drug
Research in novel drug delivery systems is being explored competitively in order to attain maximum therapeutic effect while minimizing the adverse effects. Despite several advancements in pharmaceutical formulations, one of the major challenges still persisting is sustained drug release. Microencapsulation enacts as an intelligent approach with a strong therapeutic impact and is in demand globally in medical technology due to its specific and attractive properties, including biocompatibility, stability, target specificity, uniform encapsulation, better compliance, and controlled and sustained release patterns that are responsible for diminishing the toxicity and dosage frequency. Microparticles are successful delivery systems that encapsulate both water-insoluble and sparingly water-soluble agents to elicit their efficacy with a great potential attributed to their unique properties: particle size, shape, structure, drug loading, entrapment efficiency, porosity, and release profile. Several ...
This is part of the CCB Spring Seminar Series 2016.. Abbi Abdel Rehim/Sabrya Carim, University of Manchester A Novel Approach for Attaching Targeting Ligands to Liposomal Drug Delivery Systems/IPIP, a novel player in cell division Lab: Stephen High/Martin Lowe. ...
The invention relates to a process for preparing a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a spray coating comprising a testosterone.
Scientific, peer-reviewed Dermatology article, indexed with MEDLINE/PubMed: Delivery Technologies Matter: Maximizing Efficacy and Minimizing Side Effects : No abstract available
To prevent water from flooding the structure and causing an immediate release of the drug, Grinstaff and his colleagues designed the air-filled, mesh-like material to be "superhydrophobic"-so water-resistant that droplets of water barely touch the surface, forming beads similar to those that appear on a freshly waxed car. They produced the porous polymer mesh using a process called electrospinning, which overlays micron-sized fibers upon one another. To control the rate of drug release, they adjusted chemical and physical properties of the material so that the entrapped air is loosely or tightly held. The more tightly held the air is within the structure, the harder it is for water to displace it, the slower the release, and the longer the treatment duration. Loaded with a widely used anti-cancer drug called SN-38 in in vitro experiments, the polymer mesh and internal air pocket proved to be robust and effective against lung cancer cells in solution for more than 60 days, indicating its ...
Now a day the use of herbal medicines has been increased all over the world due to their excellent and miraculous therapeutic effects and fewer side effects as compared to the modern medicines. Most of phytoconstituents of herbal extracts are water soluble and poorly miscible with oils and other lipids. Lipid solubility and molecular size of phytoconstituents are the major limiting factors for molecule to pass the biological membrane to be absorbed systemically following the oral or topical administration. The bioavailability of phytoconstituents can be increased by use of novel drug delivery system, which can increase the phytoconstituents solubility in gastrointestinal fluid as well as capacity to cross lipid rich biological membrane. Complexation of phytoconstituents with phospholipids or phosphotidylcholine results in novel drug delivery system called Phytosomes. The term phytosomes is coined from two different terms: phyto meaning plant and some meaning cell like. Phytosomes are small in size
Local drug delivery medical devices are utilized to deliver therapeutic dosages of drugs, agents or compounds directly to the site where needed. The local drug delivery medical devices utilize various materials and coating methodologies to maintain the drugs, agents or compounds on the medical device until delivered and positioned.
Global Intranasal Drug Delivery Devices Market by Manufacturers, Countries, Type and Application, Forecast to 2023. Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses. Scope of the Report: This .... February 2018 , $3480 ,View Details>> ...
A drive mechanism suitable for use in drug delivery devices is disclosed. The drive mechanism may be used with injector-type drug delivery devices, such as those permitting a user to set the delivery dose. The drive mechanism may include a housing, a dose dial sleeve, and a drive sleeve. A clutch is configured to permit rotation of the drive sleeve and the dose dial sleeve with respect to the housing when the dose dial sleeve and drive sleeve are coupled through the clutch. Conversely, when the dose dial sleeve and drive sleeve are in a de-coupled state, rotation of the dose dial sleeve with respect to the housing is permitted and rotation of the drive sleeve with respect to the housing is prevented. In the de-coupled state, axial movement of the drive sleeve transfers force in a longitudinal direction for actuation of a drug delivery device.
Marcus Horwitz and colleagues at UCLA in the U.S. will develop and test a novel drug delivery system in which nanoparticles loaded with anti-TB drugs selectively target macrophages, and release the drugs intracellularly via a pH-dependent gate, allowing delivery of high concentrations on antibiotics into the host cells for Mycobacterium tuberculosis.. ...
West is pleased to announce that it has commenced discussions with Swissfillon AG, a provider of aseptic fill and finish services to pharmaceutical and biotechnology companies, that are intended to lead to a non-exclusive global collaboration to provide fill-finish capabilities to customers using Wests proprietary SmartDose® drug delivery platform for complex molecules.
The course aims to give the participants an overview of new drugs and drug delivery systems that are approved or under clinical evaluation for treatment of cancer. The treatment of cancer is today primarily based on surgery, ionizing radiation and chemotherapy. Despite several decades of attempts to optimize these treatment regimens the mortality and morbidity is still high for many cancer indications. This together with better understanding of cancer development has paved way for alternative drugs and drug delivery technologies with potentially better specificity and efficacy. These drugs may be devided into biotherapeutics, small molecular targeted chemotherapeutics and delivery technologies to improve specificity and efficacy of drugs. The biotherapeutics include monoclonal antibodies, immunotoxins, peptides and mRNA (for cancer vaccines), DAN (for gene therapy), and oligonucleotides (for gene silencing). The new small molecular targeted chemotherapeutics inhibits in most cases signal ...
Get this from a library! Drug delivery system. [K K Jain;] -- Drug Delivery Systems, Second Edition expands upon the previous edition with current, detailed methods and technologies to further study drug delivery. With new chapters on nanobiotechnology ...
University of British Columbia researchers have developed a magnetic drug implant -- the first of its kind in Canada -- that could offer an alternative for patients struggling with numerous pills or intravenous injections.
Brain cancer is one of the most difficult malignancies to detect and treat mainly because of the difficulty in getting imaging and therapeutic agents past the blood-brain barrier and into the brain. Anti-cancer drugs such as loperamide and doxorubicin bound to nano-materials have been shown to cross the intact blood-brain barrier and released at therapeutic concentrations in the brain. Recently Scientists have developed NPs of the size of macro molecules such as DNA and proteins that are smaller than diameter of a double stranded DNA (2nm). The smallest cellular form in the world is a bacterium named mycoplasma. Which has the size of 200nm but in comparison the largest NP is only 100nm in size. Quantum dots, chitosan, Poly lactic/glycolic acid (PLGA) and PLGA-based nano particles have also been used for in vitro RNAi delivery. New Drug delivery system (DDS) has the ability to deliver drugs to specific target cells in various areas of the body without degradation in the gastrointestinal track. It ...
Drug delivery systems have rapidly evolved with new technologies that support home use and can aid in patient compliance, adherence and safety. Two areas of recent innovation, in particular, are helping pharmaceutical companies meet new market demands for self-care at home: patient-controlled delivery systems and wearable injectors. Alagu Subramaniam, Managing Director, India, West Pharmaceutical Packaging India Private Limited shares his views on evolution of drug delivery system for better patient safety
Wang, Y.; Wang, H.; Chen, Y.; Liu, X.; Jin, Q.; Ji, J., 2014: Biomimetic pseudopolyrotaxane prodrug micelles with high drug content for intracellular drug delivery
For a few years, drug delivery systems have been of wide interest to medical researchers and clinicians. These devices allow achieving targeted delivery and therefore more efficient treatment over a longer period of time. However, little is known about the underlying mechanisms of drug release, the inner structure of the systems, and the changes in exposure to the release medium. This MALDI-MSI study demonstrates the utility of MSI in a new field of pharmaceutical research by providing new insight into the spatial and temporal distributions of the compounds of advanced drug delivery systems.. ...
The development of novel drug delivery systems has improved the efficacy and safety of many important therapeutic agents. Understanding the release characteristics of drugs from these dosage forms is essential for their optimal use. In addition, knowledge of the physicochemical and biological factors that influence drug release is critical for product design. As delivery systems may be designed for either systemic or local delivery, researchers in drug delivery often function at the interface between the physical and biological sciences.
A cancer vaccine currently in clinical trials is being administered via a novel drug-delivery system. Panacea Pharmaceuticals Inc. is using the 3M Hollow Microstructured Transdermal System (hMTS) to deliver its investigational vaccine directly to the patients dermis.
... - STP Pharma Sciences ; 4: Ultimately, these systems may serve as a means for extended delivery of regenerative compounds to restore hearing in patients